SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000954
Filing Date
2021-08-05
Accepted
2021-08-05 16:39:24
Documents
71
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20210630.htm   iXBRL 10-Q 2909222
2 EX-31.1 mirm-20210630ex31_1.htm EX-31.1 16819
3 EX-31.2 mirm-20210630ex31_2.htm EX-31.2 16934
4 EX-32.1 mirm-20210630ex32_1.htm EX-32.1 9940
5 EX-32.2 mirm-20210630ex32_2.htm EX-32.2 10052
  Complete submission text file 0000950170-21-000954.txt   9721357

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20210630.xsd EX-101.SCH 67735
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20210630_lab.xml EX-101.LAB 527000
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20210630_cal.xml EX-101.CAL 47659
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20210630_pre.xml EX-101.PRE 400556
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20210630_def.xml EX-101.DEF 264412
11 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20210630_htm.xml XML 1726461
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 211148993
SIC: 2834 Pharmaceutical Preparations